WAM-1

General Information


DRACP ID  DRACP02328

Peptide Name   WAM-1

Sequence  KRGFGKKLRKRLKKFRNSIKKRLKNFNVVIPIPLPG

Sequence Length  36

UniProt ID  B1NLN8 

PubChem CID  Not available

Origin  Macropus eugenii

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
RAW 264.7 Mouse leukemia Leukemia Not active up to 128 µg/ml CCK-8 assay 24 h 1

Hemolytic Activity  Human erythrocytes: Not active up to 23.7 µM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02328

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C199H345N63O41

Absent amino acids  ACDEHMQTWY

Common amino acids  K

Mass  490077

Pl  13.13

Basic residues  14

Acidic residues  0

Hydrophobic residues  12

Net charge  14

Boman Index  -9359

Hydrophobicity  -81.67

Aliphatic Index  91.94

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  7

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 35474013

Title  Antimicrobial peptide WAM-1: a promising antibacterial and anti-inflammatory drug against carbapenem-resistant Klebsiella pneumoniae

Doi 10.1093/jac/dkac128

Year  2022

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPR_4172

DRACP is developed by Dr.Zheng's team.